Clinical Trial Update: Safety Study of XP12B in Women With Menorrhagia [Phase 3]

View source ↗

Summary

Phase 3 safety study of XP12B in women with menorrhagia completed, with results posted January 20, 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heavy Menstrual Bleeding
• Menorrhagia

Drugs mentioned

• XP12B

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Menorrhagia, Heavy Menstrual Bleeding | Phase 3 | Status: COMPLETED | Results posted: 2010-01-20